Skip to content

The Neurophysiologic monitoring of pain: the laser evoked potential (LEP) ESES therapy

The Neurophysiologic monitoring of pain: the laser evoked potential (LEP) ESES therapy - LEP-Ther

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON32385
Enrollment
25
Registered
2008-05-13
Start date
2008-07-20
Completion date
Unknown
Last updated
2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronische pijnsyndromen Failed Back Surgery Syndrome (FBSS)

Interventions

None listed

Sponsors

Sint Antonius Ziekenhuis
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients with FBSS and have received a SCS recently. Age between 18-70 years

Exclusion criteria

Exclusion criteria: Neurological or psychiatrisch disease Diabetes Mellitus (DM) Extensive vascular disease Dermatological disease at the site of planned applied stimuli

Design outcomes

Primary

MeasureTime frame
Laser evoked potential: Amplitude of N2 and P2 peaks of laser evoked potential (LEP), AUC (area under curve) of LEP between 175 - 500 ms after stimulus, latencies of N2 and P2 peaks of LEP during HF, LF stimulation and without stimulation. VAS: After each series of randomly applied stimuli, the participant is asked to estimate their subjective measurement of pain intensity on a Visual Analog Scale (VAS), these scores are compared to the VAS scores as noted in a pain diary a week before these tests.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)